.png)
Abbott Rapid Diagnostics delivers fast, accurate, and accessible testing solutions that empower better decision-making across healthcare settings. Our portfolio includes innovative tools like the ID NOW™ molecular platform and BinaxNOW™ rapid antigen tests, designed to support timely diagnosis of infectious diseases such as COVID-19, Flu A&B, RSV, and Strep-A. With a focus on reliability, ease of use, and clinical impact, we help providers in long-term care, post-acute, and community settings improve outcomes, reduce hospitalizations, and enhance operational efficiency.